Medacta Group SA (MEDGF)
160.00
0.00 (0.00%)
USD |
OTCM |
Sep 01, 16:00
Medacta Group Research and Development Expense (TTM) : 25.92M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| December 31, 2025 | 25.92M |
| June 30, 2025 | 24.56M |
| December 31, 2024 | 22.87M |
| June 30, 2024 | 22.13M |
| December 31, 2023 | 21.15M |
| June 30, 2023 | 18.04M |
| December 31, 2022 | 16.40M |
| June 30, 2022 | 16.05M |
| Date | Value |
|---|---|
| December 31, 2021 | 13.32M |
| June 30, 2021 | 9.690M |
| December 31, 2020 | 7.803M |
| June 30, 2020 | 8.188M |
| December 31, 2019 | 8.548M |
| June 30, 2019 | 5.916M |
| December 31, 2018 | 4.659M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Medartis Holding AG | 43.03M |
| Straumann Holding AG | -- |
| Metall Zug AG | 29.03M |
| Alcon AG | 1.431B |
| Ypsomed Holding AG | 49.92M |